Epigenetic therapies in hepatocellular carcinoma: emerging clinical tools and applications
Sign Up to like & getrecommendations! Published in 2025 at "Gut"
DOI: 10.1136/gutjnl-2025-336317
Abstract: Hepatocellular carcinoma (HCC) is the second leading cause of cancer death worldwide, largely due to the limited efficacy of current therapies in advanced stages of the disease. Most cases of HCC develop in the setting… read more here.
Keywords: emerging clinical; carcinoma emerging; therapies hepatocellular; epigenetic therapies ... See more keywords